Cannabinoid Antagonist SR-141716 Inhibits Endotoxic Hypotension by a Cardiac Mechanism Not Involving CB1 or CB2 Receptors

American Journal of Physiology - Heart and Circulatory Physiology - United States
doi 10.1152/ajpheart.00184.2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Prejunctional and Peripheral Effects of the Cannabinoid CB1 Receptor Inverse Agonist Rimonabant (SR 141716)

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2008English

Cannabinoid CB1/CB2 Receptors in the Heart: Expression, Regulation, and Function

2016English

Functional Characterization of the Novel Cannabinoid Receptor GPR55 and Its Modulation by CB1 and CB2 Receptors

BMC Pharmacology
2008English

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

Pharmacological Reviews
Molecular MedicinePharmacology
2010English

Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors

Neurotoxicity Research
NeuroscienceToxicology
2018English

CNS Effects of CB2 Cannabinoid Receptors: Beyond Neuro-Immuno-Cannabinoid Activity

Journal of Psychopharmacology
MedicinePsychiatryMental HealthPharmacology
2011English

Central Cannabinoid 1 Receptor Antagonist Administration Prevents Endotoxic Hypotension Affecting Norepinephrine Release in the Preoptic Anterior Hypothalamic Area

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2009English

Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients With Parkinson’s Disease

Neurotherapeutics
NeurologyPharmacology
2018English

Increased Expression of Cannabinoid CB1 Receptors in Achilles Tendinosis

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy